See All Slides - tctmd.com

Slides

Presentation TCT 2012

Challenges for Percutaneous Suture and Band Annuloplasty: Surgical Perspectives

Presenter: Robert Guyton

October 24, 2012

Presentation TCT 2012

Update on Interventions for Dialysis Fistulas

Presenter: John Bittl

October 24, 2012

Presentation TCT 2012

The Clinical Use of Renal Denervation Is Already Expanding Beyond Trial Indications: Insights from the German GREAT Registry

Presenter: Felix Mahfoud

October 24, 2012

Presentation TCT 2012

Case 5: Transseptal Puncture for Paravalvular Leak Closure

Presenter: Ramon Quesada

October 24, 2012

Presentation TCT 2012

Peer Review and Incorporation of AUC

Presenter: Christopher White

October 24, 2012

Presentation TCT 2012

V2 (Vessix Vascular)

Presenter: James Margolis

October 24, 2012

Presentation TCT 2012

"Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting...

Presenter: Hyeon-Cheol Gwon

October 24, 2012

Presentation TCT 2012

TAVR Trends in Europe and What to Expect in the Future

Presenter: Rhonda Robb

October 24, 2012

Presentation TCT 2012

Case 3: IVUS Guided Stenting in Calcified Disease

Presenter: Rainer Hoffmann

October 24, 2012

Presentation TCT 2012

As Transfemoral Devices Become Smaller, Will There Be a Role for Alternative Access?

Presenter: Martyn Thomas

October 24, 2012

Advertisement

Slides

Challenges for Percutaneous Suture and Band Annuloplasty: Surgical Perspectives

Update on Interventions for Dialysis Fistulas

The Clinical Use of Renal Denervation Is Already Expanding Beyond Trial Indications: Insights from the German GREAT Registry

Case 5: Transseptal Puncture for Paravalvular Leak Closure

Peer Review and Incorporation of AUC

V2 (Vessix Vascular)

"Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting...

TAVR Trends in Europe and What to Expect in the Future

Case 3: IVUS Guided Stenting in Calcified Disease

As Transfemoral Devices Become Smaller, Will There Be a Role for Alternative Access?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content